Ledipasvir acetone

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Ledipasvir (GS5885) 是一种 HCV NS5A 聚合酶抑制剂，用于治疗丙型肝炎病毒感染。

Ledipasvir acetone is a hepatitis C virus (HCV) NS5A inhibitor.(In Vitro):Ledipasvir acetone is considered the active ingredient, which is converted to Ledipasvir spray-dried dispersion, an amorphous free base.

Ledipasvir acetone is considered the active ingredient, which is converted to Ledipasvir spray-dried dispersion, an amorphous free base.

——

Ledipasvir acetone |

Others

Other Targets

HCV

Infection

——

1441674-54-9

947.08

C52H60F2N8O7

>98% (HPLC)

DMSO : ≥ 39 mg/mL. 41.18 mM

CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc([nH]1)c1cc2c(cc1)c1c(C2(F)F)cc(cc1)c1cc2c(cc1)nc([nH]2)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC.CC(=O)C

methyl ((S)-1-((S)-6-(5-(9,9-difluoro-7-(2-((1R,3S,4S)-2-((methoxycarbonyl)-L-valyl)-2-azabicyclo[2.2.1]heptan-3-yl)-1H-benzo[d]imidazol-6-yl)-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptan-5-yl)-3-methyl-1-oxobutan-2-yl)carbamate compound with propan-2-one (1:1)

(-20℃)

With Ice Pack

≥ 2 years